Discovery of novel thienopyrimidine derivatives as LRRK2 inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Changyu | - |
dc.contributor.author | Park, Jiwon | - |
dc.contributor.author | Jang, Soyeon | - |
dc.contributor.author | Kim, Jihyung | - |
dc.contributor.author | Lee, Sohee | - |
dc.contributor.author | Min, Kyung Hoon | - |
dc.date.accessioned | 2022-01-25T01:40:46Z | - |
dc.date.available | 2022-01-25T01:40:46Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0253-2964 | - |
dc.identifier.issn | 1229-5949 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54282 | - |
dc.description.abstract | Leucine-rich repeat kinase 2 (LRRK2) is considered a promising therapeutic target for Parkinson's disease, Crohn's disease, and cancer. Despite considerable research, none of these inhibitors are available for clinical application. Herein, we designed and synthesized novel thienopyrimidine derivatives by a bioisosteric replacement and investigated their structure-activity relationships. Thieno[3,2-d]pyrimidine derivative 22 showed the most potent inhibitory activity and inhibited both wild-type and G2019S mutant LRRK2 with IC50 values of 30 and 14 nM, respectively. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.title | Discovery of novel thienopyrimidine derivatives as LRRK2 inhibitors | - |
dc.title.alternative | Discovery of novel thienopyrimidine derivatives as LRRK2 inhibitors | - |
dc.type | Article | - |
dc.identifier.doi | 10.1002/bkcs.12450 | - |
dc.identifier.bibliographicCitation | BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.43, no.2, pp 232 - 235 | - |
dc.identifier.kciid | ART002811537 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000731931000001 | - |
dc.identifier.scopusid | 2-s2.0-85121430499 | - |
dc.citation.endPage | 235 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 232 | - |
dc.citation.title | BULLETIN OF THE KOREAN CHEMICAL SOCIETY | - |
dc.citation.volume | 43 | - |
dc.type.docType | Article | - |
dc.publisher.location | 독일 | - |
dc.subject.keywordAuthor | LRRK2 inhibitor | - |
dc.subject.keywordAuthor | thienopyrimidine | - |
dc.subject.keywordAuthor | small molecule | - |
dc.subject.keywordAuthor | Structure-activity relationship | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.